The UroLift® System Treatment

      The proven, minimally invasive treatment that fills the gap between prescription medications and more invasive surgical procedures.

      What is the UroLift System?

      Treatment with the UroLift® System is typically a one-time solution that provides rapid relief and recovery of BPH symptoms.1 It can break the cycle of medications and how they make a person feel, all without the risks of more invasive surgery. The goal of the UroLift System treatment is to relieve symptoms so you can get back to your life and resume your daily activities.

      The UroLift System treatment has demonstrated a significant improvement in symptoms for patients compared to medications.1,2 The UroLift System is the only leading BPH procedure shown not to cause new and lasting erectile or ejaculatory dysfunction*, while being a safe and effective treatment of lower urinary tract symptoms due to BPH.2-4
      faqs-437303-edited

      How Does The UroLift System Work?

      The UroLift System uses a minimally invasive approach to treating BPH that lifts and holds the enlarged prostate tissue so it no longer blocks the urethra. The treatment is performed by a urologist and does not require heating, cutting, or removal of the prostate tissue. The procedure is typically performed using local anesthesia in the outpatient clinic or day surgery unit. Patients typically return home the same day without a catheter.1
      urolift-system.jpg

      Enlarged Prostate

      An enlarged prostate can narrow or even block the urethra.

      step1

      Step 1

      The UroLift Delivery Device is placed through the obstructed urethra to access the enlarged prostate.

      step2

      Step 2

      Small UroLift Implants are permanently placed to lift and hold the enlarged prostate tissue out of the way and increase the opening of the urethra.

      step3

      Step 3

      The UroLift Delivery Device is removed, leaving an open urethra designed to provide symptom relief.

      Increased Quality of Life

      Benefits of the UroLift System include1,3,5: 

      • Does not cause new onset, sustained erectile or ejaculatory dysfunction*
      • Minimally invasive
      • Minimal downtime
      • Durable results
      • Rapid symptom relief and recovery
      • Significant improvement in quality of life

      As with any medical procedure, individual results may vary. Speak with your urologist to see if the UroLift System treatment is right for you. Most common side effects are temporary and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge.1 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.
      Treatment Options for BPH

      Source Information

      1. Roehrborn, J Urol 2013, L.I.F.T Study
      2. AUA guidelines 2003
      3. Roehrborn et al. Can J Urol 2017
      4. McVary, J Sex Med 2016
      5. Shore Can J Urol 2014

      *No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study

      INFORMATION FOR PATIENTS ABOUT THE UROLIFT® SYSTEM

      The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH), available for men 50 years or older with an enlarged prostate up to 100 cc who are looking for an alternative to drugs or major surgeries.
       

      The UroLift System’s implants, which can be delivered during an outpatient procedure, relieve prostate obstruction without heating, cutting, destruction of, or removing prostate tissue.

      The UroLift System can be used to treat a broad spectrum of anatomies, including obstructive median lobe.1 It is the only leading BPH procedure shown to not cause new onset, sustained erectile or ejaculatory dysfunction.*2-4

      Most common side effects are temporary and can include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge.5 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.

      Treatment using the UroLift System is not appropriate if you have a prostate volume greater than 100cc, a urinary tract infection or other conditions that can be identified by your urologist.

      Individual results with the UroLift System may vary.

      WARNINGS:
      1) THE UROLIFT SYSTEM’S IMPLANTS ARE PERMANENT (THAT IS TO SAY: ONCE IMPLANTED, THEY CANNOT BE COMPLETELY REMOVED).

      2) THE UROLIFT SYSTEM’S IMPLANTS CONTAIN STAINLESS STEEL AND NITINOL, AN ALLOY OF NICKEL AND TITANIUM. INDIVIDUALS WHO ARE ALLERGIC TO THESE METALS MAY SUFFER AN ALLERGIC REACTION TO THE IMPLANT. PRIOR TO HAVING A UROLIFT SYSTEM PROCEDURE, YOU SHOULD DISCUSS ANY ALLERGY/HYPERSENSITIVITY TO THESE MATERIALS WITH YOUR UROLOGIST.

      3) THE ABOVEMENTIONED INFORMATION IS NOT INTENDED TO PROVIDE MEDICAL ADVICE TO PATIENTS OR TO REPLACE THEIR DOCTORS' EXPERT OPINION AND CARE.

      4) ONLY A DOCTOR CAN DIAGNOSE WHETHER HIS/HER PATIENT HAS BPH, ASSESS HIS INDIVIDUAL CONDITION AND DEFINE WHETHER UROLIFT SYSTEM IS THE ADEQUATE TREATMENT OR NOT.

      5) TALK TO YOUR UROLOGIST FOR MORE INFORMATION ABOUT THE UROLIFT SYSTEM AND TO DETERMINE IF IT IS THE RIGHT TREATMENT FOR YOU.

      *No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study.

      1. Rukstalis, Prostate Cancer and Prostatic Dis 2018
      2. Roehrborn, Can J Urol 2017
      3. AUA BPH Guidelines 2003, 2020
      4. McVary, J Sex Med 2016
      5. Roehrborn, J Urology 2013

       

      Teleflex, BPH Relief In Sight and UroLift are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. ©2023 Teleflex Incorporated. All rights reserved. Revised: 02/2023. MC-008657 LA EN

      Teleflex Medical Brasil Ltda
      Rua Alexandre Dumas, 2100/132 - Chacara Santo Antonio
      São Paulo/SP - CEP 04717-913